1. Copyright © 2015 by the American Osteopathic Association.
From: C-Reactive Protein: A New Risk Assessment Tool for Cardiovascular Disease
J Am Osteopath Assoc. 2005;105(9): doi: /jaoa
Figure Legend:
High-sensitivity C-reactive protein adds prognostic information on vascular risk at all levels of the Framingham Risk Score (left) and all levels of low-density lipoprotein (LDL) cholesterol (right). (Adapted from Ridker PM, for the JUPITER Study Group. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Rationale and design of the JUPITER trial [review].Circulation. 2003;108[19]: )
Date of download: 3/9/2018
Copyright © 2015 by the American Osteopathic Association.
All rights reserved.